1 Results Sort by:
Biomarker for Arteriovenous Fistula Dialysis Access Failure
Application Plasma biomarker for the prediction of arteriovenous fistula (AVF) dialysis access failure during hemodialysis. Key Benefits Circulating chymase levels predict AVF failure in chronic hemodialysis patients. Proprietary antibody while other proprietary antibodies do not work as biomarkers. The ability to predict AVF failure may help...
Published: 11/6/2023       Contributor(s): Haimanot Wasse, Ahsan Husain, Angel Rivera